The PennZone

  • Home
  • Entertainment
  • Non-profit
  • Business
  • Education
  • Technology
  • Marketing
  • Music
  • Health

Lineus Medical Receives Innovative Technology Contract from Vizient for SafeBreak® Vascular
The PennZone/10180170

Trending...
  • Philadelphia Community Invited to Unite for Praise-A-Thon Summer Concert Benefiting Cobbs Creek
  • Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
  • Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
Lineus Medical
Contract awarded for products that bring improvement to health care industry

FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.

More on The PennZone
  • Crossroads4Hope Announces The Lipschutz Women's Fund
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
  • 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!
  • Harrisburg's newest restaurant, Eleve, sells out entire inventory during Grand Opening
  • New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering

"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.

"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

More on The PennZone
  • New AI Customer Segmentation Guide Warns Marketers Not to Confuse Technical Precision With Business Value
  • Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • What's New in Hokkaido, Autumn 2026
  • CRG Awarded NASA SEWP VI Contracts in Categories B and C

###

Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.

MKG-0135 Rev. 00

Source: Lineus Medical
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
  • The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
  • Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
  • MoMojo Records announces new album from Jad Tariq
  • Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
  • Fatal FOMO May be Your Last Roll of the Dice
  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
  • Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
  • Community Partnership Brings Live Theater to 150+ Young People
  • Best Rainbow Baby Charities That Support Bereaved Parents After Pregnancy Loss: A Complete Guide
  • PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
  • Former Judge Chris Oldner Honored as Best Lawyer by "D Magazine" for 6th Straight Year
  • Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
  • Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion
  • Northeast Airlines Launches New Asset Management Group
  • AI Visibility Labs LLC - Dallas Texas - July 16 2026
  • NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
  • ET&T Adds Senior Technical Voice Engineer to Strengthen Local Team
  • Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers

Popular on PennZone

  • Proper Sky Named to the 2026 MSP 501
  • Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
  • Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
  • Dentists launch independent platform to help practices choose the right technology
  • New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
  • Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Philadelphia's Own Reverend Jamie Knight Returns with "Award-Winning Love

Similar on PennZone

  • Crossroads4Hope Announces The Lipschutz Women's Fund
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
  • U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
  • Easwe D10, C20, and C30: Lightweight Folding Electric Wheelchairs Built for Easier Travel
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
  • Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us